Life sciences news

New three-year BIMZELX®▼ (bimekizumab) data reinforce long-term maintenance of complete skin clearance in moderate to severe plaque psoriasis

Wednesday September 7th 2022

Read more
BioLizard is now an Official Illumina Connected Analytics Implementation Partner

Monday September 5th 2022

Read more
flanders.bio has relocated!

Monday September 5th 2022

Read more
Nieuwe investering voor HERAN Partners: Aspect Analytics

Monday September 5th 2022

Read more
Pathomation announces new release of the “My Pathomation” cloud platform for digital pathology

Friday September 2nd 2022

Read more
Biocartis initiates commercialization in Europe of SkylineDx’s innovative Merlin™ Assay (CE-IVD) for melanoma patients

Thursday September 1st 2022

Read more
reMYND identifies novel target and small molecules with potential to halt and reverse disease progression in Huntington’s disease through oral administration

Wednesday August 31st 2022

Read more
Autoimmune disorders increase risk of cardiovascular disease

Saturday August 27th 2022

Read more
Your news here?

Become a flanders.bio member
Biocartis obtains ISO 27001 certification for information security management

Thursday August 25th 2022

Read more
Alexandra Clyde appointed to Sequana Medical Board of Directors

Thursday August 25th 2022

Read more
KU Leuven spin-off AstriVax raises € 30 million to build vaccine platform

Thursday August 25th 2022

Read more

More info?

Communication Coordinator